28611284|t|Activation of the ATF2/CREB-PGC-1alpha pathway by metformin leads to dopaminergic neuroprotection.
28611284|a|Progressive dopaminergic neurodegeneration is responsible for the canonical motor deficits in Parkinson's disease (PD). The widely prescribed anti-diabetic medicine metformin is effective in preventing neurodegeneration in animal models; however, despite the significant potential of metformin for treating PD, the therapeutic effects and molecular mechanisms underlying dopaminergic neuroprotection by metformin are largely unknown.In this study, we found that metformin induced substantial proteomic changes, especially in metabolic and mitochondrial pathways in the substantia nigra (SN). Consistent with this data, metformin increased mitochondrial marker proteins in SH-SY5Y neuroblastoma cells. Mitochondrial protein expression by metformin was found to be brain region specific, with metformin increasing mitochondrial proteins in the SN and the striatum, but not the cortex. As a potential upstream regulator of mitochondria gene transcription by metformin, PGC-1alpha promoter activity was stimulated by metformin via CREB and ATF2 pathways. PGC-1alpha and phosphorylation of ATF2 and CREB by metformin were selectively increased in the SN and the striatum, but not the cortex. Finally, we showed that metformin protected dopaminergic neurons and improved dopamine-sensitive motor performance in an MPTP-induced PD animal model. Together these results suggest that the metformin-ATF2/CREB-PGC-1alpha pathway might be promising therapeutic target for PD.
28611284	18	22	ATF2	Gene	1386
28611284	23	27	CREB	Gene	1385
28611284	28	38	PGC-1alpha	Gene	10891
28611284	50	59	metformin	Chemical	MESH:D008687
28611284	111	141	dopaminergic neurodegeneration	Disease	MESH:D009422
28611284	175	189	motor deficits	Disease	MESH:D009461
28611284	193	212	Parkinson's disease	Disease	MESH:D010300
28611284	214	216	PD	Disease	MESH:D010300
28611284	246	254	diabetic	Disease	MESH:D003920
28611284	264	273	metformin	Chemical	MESH:D008687
28611284	301	318	neurodegeneration	Disease	MESH:D019636
28611284	383	392	metformin	Chemical	MESH:D008687
28611284	406	408	PD	Disease	MESH:D010300
28611284	502	511	metformin	Chemical	MESH:D008687
28611284	561	570	metformin	Chemical	MESH:D008687
28611284	718	727	metformin	Chemical	MESH:D008687
28611284	771	792	SH-SY5Y neuroblastoma	CellLine	CVCL:0019
28611284	836	845	metformin	Chemical	MESH:D008687
28611284	890	899	metformin	Chemical	MESH:D008687
28611284	1054	1063	metformin	Chemical	MESH:D008687
28611284	1065	1075	PGC-1alpha	Gene	10891
28611284	1112	1121	metformin	Chemical	MESH:D008687
28611284	1126	1130	CREB	Gene	1385
28611284	1135	1139	ATF2	Gene	1386
28611284	1150	1160	PGC-1alpha	Gene	10891
28611284	1184	1188	ATF2	Gene	1386
28611284	1193	1197	CREB	Gene	1385
28611284	1201	1210	metformin	Chemical	MESH:D008687
28611284	1310	1319	metformin	Chemical	MESH:D008687
28611284	1364	1372	dopamine	Chemical	MESH:D004298
28611284	1407	1411	MPTP	Chemical	MESH:D015632
28611284	1420	1422	PD	Disease	MESH:D010300
28611284	1477	1486	metformin	Chemical	MESH:D008687
28611284	1487	1491	ATF2	Gene	1386
28611284	1492	1496	CREB	Gene	1385
28611284	1497	1507	PGC-1alpha	Gene	10891
28611284	1558	1560	PD	Disease	MESH:D010300
28611284	Positive_Correlation	10891	1385
28611284	Positive_Correlation	10891	1386
28611284	Negative_Correlation	MESH:D008687	MESH:D019636
28611284	Positive_Correlation	MESH:D015632	MESH:D010300
28611284	Association	MESH:D010300	10891
28611284	Positive_Correlation	MESH:D008687	1385
28611284	Positive_Correlation	MESH:D008687	10891
28611284	Negative_Correlation	MESH:D008687	MESH:D010300
28611284	Positive_Correlation	MESH:D008687	1386
28611284	Association	MESH:D010300	1385
28611284	Association	MESH:D010300	1386
28611284	Negative_Correlation	MESH:D008687	MESH:D003920

